Blue Guardian vs DNA Funded (2026) — Which Is Better?

## Overview

Blue Guardian is a UK-based proprietary trading firm offering funded accounts up to $200,000 through a structured two-phase evaluation process, ideal for traders who want clear, transparent rules and are comfortable with MetaTrader 4/5 platforms. DNA Funded is an Australian prop firm uniquely backed by an ASIC-regulated broker (DNA Markets), offering four challenge types—1-Phase, 2-Phase, Rapid, and Instant Funding—with broader instrument access (800+ CFD instruments) on the TradeLocker platform. The choice between them comes down to regulatory trust, platform preference, and challenge flexibility.

## Pricing Comparison

DNA Funded charges $49 per month versus Blue Guardian's $97 per month—DNA is nearly 50% cheaper. Both firms refund the challenge fee upon first profit payout, eliminating the upfront cost barrier for successful traders. DNA's lower entry price is significant: a trader evaluating both costs $588 annually with DNA versus $1,164 with Blue Guardian. Neither offers a free tier, but DNA's Instant Funding option lets traders skip evaluation entirely if they meet specific criteria, providing a faster path to funded capital. For traders on tight budgets or testing multiple firms simultaneously, DNA's pricing advantage is substantial and compounds over several challenge attempts.

## Key Features Head-to-Head

**Platform & Trading Tools**: Blue Guardian locks traders into MetaTrader 4/5, limiting customization and third-party integration options. DNA Funded uses TradeLocker, a modern, cloud-based platform with superior charting, more flexible order types, and better mobile support. TradeLocker is the clear winner for traders who want professional-grade tools without MT4's legacy constraints.

**Instrument Diversity**: DNA provides 800+ CFD instruments including forex, commodities, indices, and stocks. Blue Guardian operates within MT4/MT5 availability but offers no cryptocurrency pairs at all. DNA restricts crypto only in the Rapid challenge, meaning traders pursuing 1-Phase or 2-Phase challenges access a far broader asset universe. This heavily favors DNA for traders diversifying across multiple instrument classes.

**Challenge Flexibility**: Blue Guardian offers one path—a two-phase evaluation. DNA offers four: 1-Phase (fewer rules, longer evaluation), 2-Phase (stricter), Rapid (quick but with restrictions), and Instant Funding (skip evaluation if you meet criteria). This flexibility is enormous; traders stressed by evaluation time limits or wanting to prove themselves fast have genuine options with DNA.

**Regulatory Backing**: Blue Guardian is a standalone proprietary firm. DNA is backed by DNA Markets, an ASIC-regulated Australian broker—a rare and legitimate credibility marker in the prop trading space. This means DNA's capital, leverage, and risk controls are overseen by an actual financial regulator. For traders prioritizing legitimacy and protection, this is a decisive advantage for DNA.

**Spreads & Execution**: DNA advertises raw spreads from 0.0 pips on a TradeLocker platform designed for minimal latency. Blue Guardian's spread structure isn't specified, and MT4/5 execution on third-party brokers is typically less competitive. DNA's transparent spread structure is better for scalpers and high-frequency traders.

**Profit Split**: Both offer 80% profit splits on funded accounts—equal terms here.

## Who Should Choose Blue Guardian

- **MT4/MT5 specialists**: If your entire trading system, indicators, and EAs are built for MetaTracer, Blue Guardian is the path of least resistance; switching platforms isn't worth the risk. - **Algorithmic traders using Expert Advisors**: Blue Guardian explicitly permits automated strategies and advisor usage; traders leaning heavily on bots should verify DNA Funded's EA restrictions before committing. - **Traders seeking UK/EU regulation**: If you prefer a UK-based firm (even if not formally regulated like DNA's ASIC backing), Blue Guardian's jurisdiction may feel more familiar. - **Larger account sizes**: With up to $200,000 available accounts, Blue Guardian appeals to experienced traders who've already proven themselves and want maximum capital to deploy.

## Who Should Choose DNA Funded

- **Budget-conscious traders**: At $49/month versus $97, DNA saves money on multiple evaluation attempts—critical if you fail a challenge and restart. - **Traders wanting regulatory assurance**: ASIC backing is genuine oversight; traders paranoid about prop firm legitimacy should choose DNA. - **Multi-asset traders**: If you trade forex, commodities, indices, and stocks (but not crypto), DNA's 800+ CFD instruments blow away MT4/MT5 limitations. This is essential for diversification-focused traders. - **Traders uncomfortable with long evaluations**: DNA's Instant Funding option (skip evaluation entirely) and 1-Phase (no time limit) cater to traders who chafe under strict evaluation windows. Blue Guardian forces the two-phase commitment with no alternatives.

## The Verdict

DNA Funded is the better choice for most traders in 2026: it's 50% cheaper, regulated by ASIC through DNA Markets, offers four different challenge paths instead of one, and provides 800+ tradeable instruments instead of MT4/MT5 restrictions. Blue Guardian wins only if you're an MT4/MT5-dependent algorithmic trader or you specifically need account sizes larger than DNA offers. For everyone else—budget-aware traders, those valuing regulatory protection, and traders wanting platform flexibility—DNA Funded delivers more features, more options, and better value at half the monthly cost.